Transcat Inc (NASDAQ: TRNS) is a calibration services and test instrumentation distribution company that provides accredited calibration, cost control and optimization services, and distribution and rental of professional grade handheld test, measurement, and control instrumentation. Revenue is generated through two segments: a Service segment that charges fees for calibration and compliance services, and a Distribution segment that sells and rents instrumentation to customers in regulated industries. Transcat targets highly regulated end markets, particularly life sciences, pharmaceutical manufacturing, medical device manufacturing, and industries governed by the U.S. FDA and FAA. The company operates calibration service centers across North America, Puerto Rico, and Ireland, and claims the largest ISO/IEC 17025 scope of accreditation of any commercial calibration laboratory serving its target markets (per the FY2025 10-K filed 2025-05-27). Proprietary software platforms CalTrak and C3 create switching costs by integrating calibration management into customer workflows. The Service segment competes in a fragmented market ranging from large accredited corporations to sole proprietors, while the Distribution segment faces numerous manufacturers and distributors.
Accredited calibration services under the 'Calibrated by Transcat' brand; compliance services; cost control and optimization services (Transcat Cost Control and Optimization Services); Single Source Solution bundling product distribution with services; distribution and rental of professional grade handheld test, measurement, and control instrumentation; proprietary calibration management software CalTrak and C3.
Two-segment model: the Service segment earns fees for calibration, compliance, and optimization services delivered at Transcat-operated labs and customer sites; the Distribution segment generates transactional revenue from sales and rentals of professional grade test, measurement, and control instrumentation across North America and internationally.
Customers in highly regulated industries, with particular focus on life sciences, pharmaceutical manufacturing, and medical device manufacturing. End markets are driven by regulatory requirements from the U.S. FDA, FAA, and other regulatory bodies that mandate calibration as a component of quality compliance programs.
Operations span North America, Puerto Rico, and Ireland, per the FY2025 10-K filed 2025-05-27. Canadian operations are headquartered in Montreal, QC. Corporate headquarters and primary calibration service center are in Rochester, NY.
Loading...